Aiden Haghikia - Publications

Affiliations: 
Ruhr-University Bochum/St. Josefs Hospital, Bochum, Nordrhein-Westfalen, Germany 

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Haase S, Wilck N, Haghikia A, Gold R, Mueller DN, Linker RA. The role of the gut microbiota and microbial metabolites in neuroinflammation. European Journal of Immunology. PMID 33188704 DOI: 10.1002/eji.201847807  0.313
2020 Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J, Zelic M, Mahan A, Kothe M, Scholte AA, Fitzgerald M, ... ... Haghikia A, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death & Disease. 11: 904. PMID 33097690 DOI: 10.1038/s41419-020-03084-7  0.32
2020 Gold R, Montalban X, Haghikia A. Multiple sclerosis and nutrition: back to the future? Therapeutic Advances in Neurological Disorders. 13: 1756286420936165. PMID 32863887 DOI: 10.1177/1756286420936165  0.394
2020 Wurm H, Attfield K, Iversen AK, Gold R, Fugger L, Haghikia A. Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520943791. PMID 32762494 DOI: 10.1177/1352458520943791  0.362
2020 Waldera-Lupa DM, Poschmann G, Kirchgaessler N, Etemad-Parishanzadeh O, Baberg F, Brocksieper M, Seidel S, Kowalski T, Brunn A, Haghikia A, Gold R, Stefanski A, Deckert M, Schlegel U, Stühler K. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers. 12. PMID 32610669 DOI: 10.3390/Cancers12071732  0.32
2020 Ostendorf F, Metzdorf J, Gold R, Haghikia A, Tönges L. Propionic Acid and Fasudil as Treatment Against Rotenone Toxicity in an In Vitro Model of Parkinson's Disease. Molecules (Basel, Switzerland). 25. PMID 32481507 DOI: 10.3390/Molecules25112502  0.323
2020 Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, Schneider R, Troisi R, Zent D, Hegelmaier T, Dokalis N, ... ... Haghikia A, et al. Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism. Cell. PMID 32160527 DOI: 10.1016/J.Cell.2020.02.035  0.759
2020 Habib R, Ocklenburg S, Hoffjan S, Haghikia A, Epplen JT, Arning L. Association between shorter leukocyte telomeres and multiple sclerosis. Journal of Neuroimmunology. 341: 577187. PMID 32050150 DOI: 10.1016/J.Jneuroim.2020.577187  0.416
2020 Linker RA, Haghikia A. Rolle des Darmes bei der Multiplen Sklerose Nervenheilkunde. 39: 42-46. DOI: 10.1055/A-1037-2166  0.375
2019 Schäfer I, Kaisler J, Scheller A, Kirchhoff F, Haghikia A, Faissner A. Conditional Deletion of LRP1 Leads to Progressive Loss of Recombined NG2-Expressing Oligodendrocyte Precursor Cells in a Novel Mouse Model. Cells. 8. PMID 31801252 DOI: 10.3390/Cells8121550  0.346
2019 Kramer S, Haghikia A, Bang C, Scherf K, Pfanne A, Duscha A, Kaisler J, Gisevius B, Gold R, Thum T, Haghikia A. Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: A validation study. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e623. PMID 31575652 DOI: 10.1212/Nxi.0000000000000623  0.32
2019 Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, et al. [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Der Nervenarzt. PMID 31297574 DOI: 10.1007/S00115-019-0760-0  0.344
2019 Hirschberg S, Gisevius B, Duscha A, Haghikia A. Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases. International Journal of Molecular Sciences. 20. PMID 31242699 DOI: 10.3390/Ijms20123109  0.333
2019 Zorlu N, Hoffjan S, Haghikia A, Deyneko IV, Epplen JT. Evaluation of variation in genes of the arylhydrocarbon receptor pathway for an association with multiple sclerosis. Journal of Neuroimmunology. 334: 576979. PMID 31181469 DOI: 10.1016/J.Jneuroim.2019.576979  0.412
2019 Krogias C, Christou I, Tsivgoulis G, Koutroulou I, Schroeder C, Lantinioti C, Richter D, Karapanayiotides T, Haghikia A, Gold R, Voumvourakis K. Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 30990241 DOI: 10.1111/Jon.12617  0.397
2019 Vohl K, Duscha A, Gisevius B, Kaisler J, Gold R, Haghikia A. Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis. Frontiers in Neurology. 10: 132. PMID 30853935 DOI: 10.3389/Fneur.2019.00132  0.333
2019 Dalla Costa G, Martinelli V, Moiola L, Sangalli F, Colombo B, Finardi A, Cinque P, Kolb EM, Haghikia A, Gold R, Furlan R, Comi G. Serum neurofilaments increase at PML onset in natalizumab-treated MS patients. Annals of Neurology. PMID 30761586 DOI: 10.1002/Ana.25437  0.42
2018 Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A. Peripheral CD19 B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders. Journal of Neurology. PMID 30377816 DOI: 10.1007/S00415-018-9092-4  0.4
2018 Schroeder C, Back C, Koc Ü, Strassburger-Krogias K, Reinacher-Schick A, Gold R, Haghikia A. Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis. Clinical Neurology and Neurosurgery. 172: 24-26. PMID 29960102 DOI: 10.1016/J.Clineuro.2018.06.005  0.306
2018 Motte J, Kneiphof J, Straßburger-Krogias K, Klasing A, Adams O, Haghikia A, Gold R. Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML. Journal of Neurology. PMID 29948248 DOI: 10.1007/S00415-018-8931-7  0.326
2018 Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, Gold R, Linker RA. The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Annals of Clinical and Translational Neurology. 5: 668-676. PMID 29928650 DOI: 10.1002/Acn3.553  0.435
2018 Haase S, Haghikia A, Wilck N, Müller DN, Linker RA. Impacts of microbiome metabolites on immune regulation and autoimmunity. Immunology. PMID 29637999 DOI: 10.1111/Imm.12933  0.392
2018 Haghikia A, Linker RA. Ernährung, Mikrobiom und Multiple Sklerose Nervenarzt. 89: 463-471. PMID 29516151 DOI: 10.1007/S00115-018-0497-1  0.407
2018 Matveeva O, Bogie JFJ, Hendriks JJA, Linker RA, Haghikia A, Kleinewietfeld M. Western lifestyle and immunopathology of multiple sclerosis. Annals of the New York Academy of Sciences. 1417: 71-86. PMID 29377214 DOI: 10.1111/Nyas.13583  0.408
2018 Haase S, Haghikia A, Gold R, Linker RA. Dietary fatty acids and susceptibility to multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 12-16. PMID 29307296 DOI: 10.1177/1352458517737372  0.444
2018 Haghikia A, Linker R. Diät, Mikrobiom und Multiple Sklerose Aktuelle Neurologie. 45: 24-28. DOI: 10.1055/S-0043-111789  0.359
2017 Hammer A, Schliep A, Jörg S, Haghikia A, Gold R, Kleinewietfeld M, Müller DN, Linker RA. Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation. Journal of Neuroinflammation. 14: 184. PMID 28899400 DOI: 10.1186/S12974-017-0954-Y  0.359
2017 Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S, Linker RA, Gold R, Haghikia A. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. The American Journal of Pathology. 187: 1613-1622. PMID 28634006 DOI: 10.1016/J.Ajpath.2017.03.006  0.755
2017 Schneider R, Bellenberg B, Hoepner R, Kolb EM, Ellrichmann G, Haghikia A, Gold R, Lukas C. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). Plos One. 12: e0176415. PMID 28445498 DOI: 10.1371/Journal.Pone.0176415  0.337
2017 Haghikia A, Dendrou CA, Schneider R, Grüter T, Postert T, Matzke M, Stephanik H, Fugger L, Gold R. Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. The Lancet. Neurology. 16: 104-106. PMID 28102146 DOI: 10.1016/S1474-4422(16)30382-9  0.306
2016 Haghikia A, Gold R. Active immunotherapy may delay disability in progressive MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27683917 DOI: 10.1136/Jnnp-2016-314377  0.412
2016 Berg J, Mahmoudjanlou Y, Duscha A, Massa MG, Thöne J, Esser C, Gold R, Haghikia A. The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor. Journal of Neuroimmunology. 298: 9-15. PMID 27609269 DOI: 10.1016/J.Jneuroim.2016.06.003  0.718
2016 Jörg S, Grohme DA, Erzler M, Binsfeld M, Haghikia A, Müller DN, Linker RA, Kleinewietfeld M. Environmental factors in autoimmune diseases and their role in multiple sclerosis. Cellular and Molecular Life Sciences : Cmls. PMID 27491297 DOI: 10.1007/S00018-016-2311-1  0.395
2016 Linker RA, Haghikia A. Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy. Therapeutic Advances in Chronic Disease. 7: 198-207. PMID 27433310 DOI: 10.1177/2040622316653307  0.371
2016 Faissner S, Nikolayczik J, Chan A, Gold R, Yoon MS, Haghikia A. Immunoadsorption in patients with neuromyelitis optica spectrum disorder. Therapeutic Advances in Neurological Disorders. 9: 281-6. PMID 27366234 DOI: 10.1177/1756285616646332  0.304
2016 Massa MG, Gisevius B, Hirschberg S, Hinz L, Schmidt M, Gold R, Prochnow N, Haghikia A. Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells. Plos One. 11: e0155274. PMID 27158987 DOI: 10.1371/Journal.Pone.0155274  0.737
2016 Faissner S, Nikolayczik J, Chan A, Hellwig K, Gold R, Yoon MS, Haghikia A. Plasmapheresis and immunoadsorption in patients with steroid refractory multiple sclerosis relapses. Journal of Neurology. PMID 27039388 DOI: 10.1007/S00415-016-8105-4  0.374
2016 Jörg S, Kissel J, Manzel A, Kleinewietfeld M, Haghikia A, Gold R, Müller DN, Linker RA. High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells. Experimental Neurology. 279: 212-222. PMID 26976739 DOI: 10.1016/J.Expneurol.2016.03.010  0.342
2016 Haghikia A, Gold R. Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome. Jama Neurology. PMID 26954938 DOI: 10.1001/Jamaneurol.2015.5050  0.308
2016 Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, et al. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt. PMID 26927677 DOI: 10.1007/S00115-016-0077-1  0.395
2016 Akkad DA, Lee DH, Bruch K, Haghikia A, Epplen JT, Hoffjan S, Linker RA. Multiple sclerosis in families: risk factors beyond known genetic polymorphisms. Neurogenetics. PMID 26865406 DOI: 10.1007/S10048-016-0474-4  0.366
2015 Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, et al. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. Immunity. 43: 817-29. PMID 26488817 DOI: 10.1016/J.Immuni.2015.09.007  0.362
2015 Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B, Menck S, Gold R, Langer-Gould A. Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. Jama Neurology. 72: 1132-8. PMID 26322399 DOI: 10.1001/Jamaneurol.2015.1806  0.4
2015 Kolber P, Luessi F, Meuth SG, Klotz L, Korn T, Trebst C, Tackenberg B, Kieseier B, Kümpfel T, Fleischer V, Tumani H, Wildemann B, Lang M, Flachenecker P, Meier U, ... ... Haghikia A, et al. [Current aspects of therapy conversion for multiple sclerosis]. Der Nervenarzt. 86: 1236-47. PMID 26269289 DOI: 10.1007/S00115-015-4368-8  0.376
2015 Akkad DA, Olischewsky A, Reiner F, Hellwig K, Esser S, Epplen JT, Curk T, Gold R, Haghikia A. Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity. Plos One. 10: e0127632. PMID 26011527 DOI: 10.1371/Journal.Pone.0127632  0.376
2015 Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry. Multiple Sclerosis and Related Disorders. 4: 264-72. PMID 26008944 DOI: 10.1016/J.Msard.2015.04.003  0.332
2015 Haghikia A, Gold R. [Is the use of placebo as control group in MS drug trials still appropriate?]. Der Nervenarzt. 86: 481-2. PMID 25787726 DOI: 10.1007/S00115-015-4283-Z  0.325
2015 Akkad DA, Bellenberg B, Esser S, Weiler F, Epplen JT, Gold R, Lukas C, Haghikia A. Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability. Neurogenetics. 16: 161-8. PMID 25620546 DOI: 10.1007/S10048-015-0438-0  0.377
2014 Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K. Natalizumab use during the third trimester of pregnancy. Jama Neurology. 71: 891-5. PMID 24821217 DOI: 10.1001/Jamaneurol.2014.209  0.31
2014 Haghikia A, Linker R, Gold R. [Fumaric acid as therapeutic agent for multiple sclerosis]. Der Nervenarzt. 85: 720-6. PMID 24668400 DOI: 10.1007/S00115-014-4005-Y  0.379
2014 Haghikia A, Gold R. Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS. Nature Reviews. Neurology. 10: 183-4. PMID 24638132 DOI: 10.1038/Nrneurol.2014.42  0.421
2014 Berg J, Bytko X, Waldhoff C, Gold R, Haghikia A. Effect of MS-related miRNA on astrocytic proliferation Journal of Neuroimmunology. 275: 111. DOI: 10.1016/J.Jneuroim.2014.08.298  0.33
2013 Prochnow N, Gold R, Haghikia A. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 264: 48-53. PMID 24090654 DOI: 10.1016/J.Jneuroim.2013.09.012  0.332
2013 Haghikia A, Gold R. [Multiple sclerosis: oral drugs]. Mmw Fortschritte Der Medizin. 155: 54-6. PMID 24006598 DOI: 10.1007/S15006-013-2042-2  0.318
2013 Haghikia A, Hohlfeld R, Gold R, Fugger L. Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends in Molecular Medicine. 19: 309-19. PMID 23582699 DOI: 10.1016/J.Molmed.2013.03.004  0.41
2013 Décard BF, Haghikia A, Tönnes C, Thöne J, Lukas C, Chan A, Gold R. Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 249-51. PMID 22596228 DOI: 10.1177/1352458512448268  0.351
2013 Burek M, Haghikia A, Gold R, Roewer N, Chan A, Frster CY. Differential Cytokine Release from Brain Microvascular Endothelial Cells Treated with Dexamethasone and Multiple Sclerosis Patient Sera Journal of Steroids & Hormonal Science. 5: 1-8. DOI: 10.4172/2157-7536.1000128  0.433
2012 Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T, Gold R. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology. 79: 2166-70. PMID 23077021 DOI: 10.1212/Wnl.0B013E3182759621  0.326
2012 Hellwig K, Haghikia A, Rockhoff M, Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Therapeutic Advances in Neurological Disorders. 5: 247-53. PMID 22973421 DOI: 10.1177/1756285612453192  0.356
2012 Gregory AP, Dendrou CA, Attfield KE, Haghikia A, Xifara DK, Butter F, Poschmann G, Kaur G, Lambert L, Leach OA, Prömel S, Punwani D, Felce JH, Davis SJ, Gold R, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature. 488: 508-11. PMID 22801493 DOI: 10.1038/Nature11307  0.387
2012 Thöne J, Ellrichmann G, Faustmann PM, Gold R, Haghikia A. Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis. International Immunopharmacology. 14: 9-12. PMID 22691576 DOI: 10.1016/J.Intimp.2012.05.021  0.306
2012 Haghikia A, Décard BF, Hellwig K, Kraus P, Gold R. Wheels within wheels: multifocal autoimmune myelitis in a woman with Huntington's disease. Journal of Neurology. 259: 1973-5. PMID 22460588 DOI: 10.1007/S00415-012-6484-8  0.311
2012 Minwegen D, Poschmann G, Stuehler K, Faissner S, Haghikia A, Meyer H, Gold R, Chan A. Astrocytes Secrete Bridging Molecules That May Be Responsible for Increased Microglial Uptake of Apoptotic Inflammatory Cells (P07.090) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.090  0.325
2011 Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 958-63. PMID 21613333 DOI: 10.1177/1352458511401944  0.303
2011 Sørensen PS, Jensen PE, Haghikia A, Lundkvist M, Vedeler C, Sellebjerg F, Koch-Henriksen N, Fogdell-Hahn A, Myhr KM, Hillert J, Gold R. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1074-8. PMID 21511692 DOI: 10.1177/1352458511404271  0.369
2011 Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O, Zéphir H, Gold R. Managing MS in a changing treatment landscape. Journal of Neurology. 258: 728-39. PMID 21437661 DOI: 10.1007/S00415-011-6009-X  0.422
2010 Blecharz KG, Haghikia A, Stasiolek M, Kruse N, Drenckhahn D, Gold R, Roewer N, Chan A, Förster CY. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 293-302. PMID 20203147 DOI: 10.1177/1352458509358189  0.38
2010 Hellwig K, Haghikia A, Gold R. Parenthood and immunomodulation in patients with multiple sclerosis. Journal of Neurology. 257: 580-3. PMID 19936821 DOI: 10.1007/S00415-009-5376-Z  0.396
2009 Hellwig K, Haghikia A, Agne H, Beste C, Gold R. Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Archives of Neurology. 66: 1580-1; author reply. PMID 20008670 DOI: 10.1001/Archneurol.2009.281  0.328
2009 Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. The New England Journal of Medicine. 361: 1075-80. PMID 19741228 DOI: 10.1056/Nejmoa0810257  0.33
2009 Haghikia A, Gold R. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis? Experimental Neurology. 217: 240-1. PMID 19361499 DOI: 10.1016/J.Expneurol.2009.03.041  0.329
2009 Hellwig K, Haghikia A, Gold R. Vaterschaft und Immunodulation bei Patienten mit Multipler Sklerose Aktuelle Neurologie. 36: 488. DOI: 10.1055/S-0029-1238582  0.354
2008 Haghikia A, Fischer M, Hellwig K, Linker R, Chan A, Hohlfeld R, Gold R. Open use of natalizumab. Neutralising antibodies and clinical data Nervenarzt. 79: 716-719. PMID 18437340 DOI: 10.1007/S00115-008-2464-8  0.339
2008 Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S, Gold R. Increased MS relapse rate during assisted reproduction technique. Journal of Neurology. 255: 592-3. PMID 18408881 DOI: 10.1007/S00415-008-0607-2  0.354
2008 Hellwig K, Brune N, Haghikia A, Müller T, Schimrigk S, Schwödiauer V, Gold R. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients Acta Neurologica Scandinavica. 118: 24-28. PMID 18205883 DOI: 10.1111/J.1600-0404.2007.00978.X  0.377
2008 Haghikia A, Fischer M, Hellwig K, Linker R, Chan A, Hohlfeld R, Gold R. Natalizumab im klinischen Alltag Nervenarzt. 79: 716-719. DOI: 10.1007/S00115-008-2558-3  0.375
2007 Hellwig K, Haghikia A, Schimrigk S, Gold R. Kinderwunsch und Multiple Sklerose Einstellungs- und Verschreibungsverhalten deutschsprachiger Neurologen Aktuelle Neurologie. 34: 495. DOI: 10.1055/S-2007-987766  0.351
Show low-probability matches.